FGF19 and type 2 diabetes mellitus: To test further the hypothesis that hepatic gene expression in the FGF19-FGF21 axis is dysregulated in diabetes, we compared gene expression levels (mRNA determined by real time qPCR) between T2D and No-T2D patients (Table A in S1 File).